ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
SA-BDP.pdf (2.18 MB)

Synthesis and Characterization of Stearic Acid-Beclomethasone Dipropionate Conjugates with the Potential for Improving Loading Capacity in Lipid-based Nanoparticles

preprint
submitted on 05.01.2021, 03:48 and posted on 11.01.2021, 06:23 by Shishuai Dang, Zhengwei Huang, Ying Huang, Xin Pan, Chuanbin Wu

Lipid-based nanoparticles (LBNs) are a new type of nanoparticulate drug delivery system, which have been gradually shown broad prospects in pulmonary drug delivery systems. However, the main disadvantage of these LBNs for inhalable drugs with limited lipophilicity is the low encapsulation capacity. Herein, this study anticipates establishing a technology platform to improve the loading capacity of low lipophilicity drugs in LBNs, for the therapy of lung diseases. A proof-of-concept was carried out using Beclomethasone dipropionate (BDP) as a model drug. BDP was conjugated with stearic acid (SA), a kind of the lipid matrix for LBN. The conjugate was characterized and the interactions between the conjugate and SA were investigated by molecular dynamics simulation. It is expected that the drug loading capacity of weak-lipophilic drugs in LBN can be increased by establishing the technology platform, and the application of LBNs in pulmonary delivery can be broadened.

Funding

Special Funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation (“Climbing Program” Special Funds) number pdjh2019a0003

National Natural Science Foundation of China

National Natural Science Foundation of China

Find out more...

History

Email Address of Submitting Author

shishuaidang@163.com

Institution

Sun Yat-sen University

Country

China

ORCID For Submitting Author

0000-0002-0241-9070

Declaration of Conflict of Interest

no conflict of interest